tiprankstipranks
Molecular Partners (MOLN)
NASDAQ:MOLN
US Market
MOLN
Molecular Partners
RESEARCH TOOLSreports
Want to see MOLN full AI Analyst Report?

Molecular Partners (MOLN) Stock News & Sentiment

45 Followers
Molecular Partners Showcases Nature Cancer Phase 1 Data and Advances MP0317 Into Phase 2 Cholangiocarcinoma Trial
Premium
Company Announcements
Molecular Partners Showcases Nature Cancer Phase 1 Data and Advances MP0317 Into Phase 2 Cholangiocarcinoma Trial
8d ago
6K
MOLN
Molecular Partners: Unmodeled Upside from MP0632 AND-Gate T Cell Engager Supports Buy Rating and $13 Target
Premium
Ratings
Molecular Partners: Unmodeled Upside from MP0632 AND-Gate T Cell Engager Supports Buy Rating and $13 Target
17d ago
MOLN
Molecular Partners Adds Deal Veteran to Board as Shareholders Back All AGM Proposals
Premium
Company Announcements
Molecular Partners Adds Deal Veteran to Board as Shareholders Back All AGM Proposals
24d ago
6K
MOLN
Molecular Partners Sets 2026 AGM, Nominates Clare Fisher to Board as Long-Serving Director Steps Down
Premium
Company Announcements
Molecular Partners Sets 2026 AGM, Nominates Clare Fisher to Board as Long-Serving Director Steps Down
1M ago
6K
MOLN
3 Best Stocks to Buy Today, 3/16/2026, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Today, 3/16/2026, According to Top Analysts
2M ago
MOLN
SVCO
Molecular Partners: Strong Cash Runway and Pipeline Catalysts Support DCF‑Backed Buy Rating and $13 Target
Premium
Ratings
Molecular Partners: Strong Cash Runway and Pipeline Catalysts Support DCF‑Backed Buy Rating and $13 Target
2M ago
MOLN
Undervalued Radioligand Leader: Molecular Partners’ Differentiated RadioDARPin Platform Underpins Buy Rating
Premium
Ratings
Undervalued Radioligand Leader: Molecular Partners’ Differentiated RadioDARPin Platform Underpins Buy Rating
2M ago
MOLN
More MOLN News >

MOLN News on the Web

Molecular Partners announces presentation of preclinical data at AACR
TipRanks News
Bullish
Molecular Partners Adds Deal Veteran to Board as Shareholders Back All AGM Proposals
TipRanks News
Bearish
Molecular Partners Sets 2026 AGM, Nominates Clare Fisher to Board as Long-Serving Director Steps Down
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: ProKidney (PROK), Molecular Partners (MOLN) and Bristol-Myers Squibb (BMY)
TipRanks News
Bullish
3 Best Stocks to Buy Today, 3/16/2026, According to Top Analysts
TipRanks News
Bullish
Molecular Partners: Strong Cash Runway and Pipeline Catalysts Support DCF‑Backed Buy Rating and $13 Target
TipRanks News
Bullish
Undervalued Radioligand Leader: Molecular Partners’ Differentiated RadioDARPin Platform Underpins Buy Rating
TipRanks News
Bullish
Molecular Partners Posts 2025 Results, Advances Radio-DARPins and Oncology Pipeline
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
MOLN
Sector Average
Media Buzz
This Week2 articles
Weekly Average0.5 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MOLN’s Media Buzz Sentiment?
2 articles about MOLN were published this week. In an average week, 0.5 articles are published.
    What is MOLN’s weekly average amount of articles?
    In an average week, 0.5 articles about MOLN are published.
      What is MOLN’s News Sentiment?
      50% of articles about MOLN were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week